Open access peer-reviewed Compact

Our Journey Beyond Sunset Boulevard

Evidence-based Analysis of Tumor-Targeted Gene- and Immuno-Therapies Shine a Critical Spotlight on “True” Long-Term Cancer-Free Survival

Authored by

Erlinda M. Gordon

Delta Next-Gene, LLC, Santa Monica

Frederick Hall

Delta Next-Gene, LLC, Santa Monica

The revival of DeltaRex-G (formerly Rexin-G)—the first proactive tumor-hunting/tumor-killing biomedicine of this kind in history—returned active tumor surveillance and a precision-guided “silver bullet” (dnG1 killer gene) to the cancer clinic with “Expanded Access” in 2019. Empowered by US Right-to-Try legislation, while honoring ethical principles of “informed consent,” this unique graphic/picturesque presentation of clinical and translational medicine is intended for postmodern (post-Enlightenment) layman readers, including cancer patients, students, researchers, and future practitioners in the field of precision gene-based medicine. Confronting logical fallacies in popular opinion, the authors present newsworthy, up-to-date clinical research documenting the successful management of refractory metastatic cancers with tumor-targeted gene therapy vectors—validating “pathotropic” (disease-seeking) tumor targeting avant la lettre.

Read more >Order hardcopy
Our Journey Beyond Sunset BoulevardEvidence-based Analysis of Tumor-Targeted Gene- and Immuno-Therapies Shine a Critical Spotlight on “True” Long-Term Cancer-Free SurvivalAuthored by Erlinda M. Gordon and Frederick Hall

Published: May 5th 2021

DOI: 10.5772/intechopen.95307

ISBN: 978-1-83969-416-5

Print ISBN: 978-1-83969-415-8

eBook (PDF) ISBN: 978-1-83969-417-2

Copyright year: 2021

Books open for chapter submissions

89 Total Compact Downloads

Compact and compacts are indexed in

  • Worldcat
  • OpenAIRE
  • Google Scholar
  • AZ ebsco
  • Base
  • CNKI

Order a hardcopy of the Compact

Free shipping with DHL Express

Hardcover (ex. VAT)£100

Order now

Residents of European Union countries need to add a Book Value-Added Tax Rate based on their country of residence. Institutions and companies, registered as VAT taxable entities in their own EU member state, will not pay VAT by providing IntechOpen with their VAT registration number. This is made possible by the EU reverse charge method.

Special discount for IntechOpen contributors

All IntechOpen contributors are offered special discounts starting at 40% OFF available through your personal dashboard

Login and purchase